DC Medical is a medical device company utilizing Korea's first NRDO (No Research Develop Only) business model to streamline the development process of medical technologies. This approach addresses the inefficiencies in traditional research and development by focusing on the commercialization of existing innovations, thereby accelerating access to essential medical devices.
Funding
$4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional medical device development often faces inefficiencies due to the complexities and time-consuming nature of in-house research and development processes. This can lead to delays in bringing essential medical technologies to market, hindering access for patients and healthcare providers.
Solution
DC Medical streamlines the development and commercialization of medical technologies by utilizing a No Research, Development Only (NRDO) business model. This approach focuses on sourcing and developing existing innovations rather than conducting original research. By concentrating on the commercialization phase, DC Medical aims to accelerate the availability of essential medical devices, addressing critical healthcare needs more efficiently. This model allows for a faster and more cost-effective pathway to market for promising medical technologies.
Target Audience
The primary target audience includes healthcare providers, hospitals, and patients seeking access to innovative and essential medical devices.
Features
- Focus on in-licensing and acquiring existing medical device technologies.
- Streamlined development process bypassing traditional research phases.
- Accelerated commercialization of essential medical devices.